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2',6'-Diphenyl-3,4'-bipyridines 3a-t have been achieved by the three-component, one-pot reaction of nicotinaldehydes 
1a-b, acetophenones 2a-j and anhydrous ammonium acetate under solvent free conditions at 120°C. All the prepared 
compounds 3a-t have been screened for anti-microbial, free-radical scavenging and α-glucosidase inhibitory activities. 
Compounds 3m-r have shown anti-bacterial activity and compounds 3m-n identified as anti-fungal agents. Compounds 3d, 
3h, 3m and 3r-s have shown α-glucosidase inhibitory activity. 
Keywords: Nicotinaldehydes, 2',6'-diphenyl-3,4'-bipyridines, anti-microbial activity, α-glucosidase inhibitory activity 
Pyridines represent an important class of heterocyclic 
compounds and structural units present in natural 
products and pharmaceuticals
1,2
. These are the key 
intermediates for the preparation of biologically 
active molecules2. Isoniazid (anti-tubercular drug)3 
and Imidacloprid (pesticide molecule)
4
 are the 
potential pyridine derivatives. 2,4,6-Triarylpyridines 
or 2,6-diaryl-4-heteroarylpyridines are important 
heterocyclic compounds and the construction of  
2,4,6-triarylpyridines have been reported by  
Chen et al.
5
 from acetophenone (3 equiv.) and 
NH4OAc (nitrogen source) in the presence of 
Cu(OTf)2 in toluene at 110°C. Preparation of  
2,4,6-trisubstituted pyridines was reported by Jiang 
et al. from acetophenones and nicotinal 
aminescatalyzed by Cu(OTf)2/O2 with the cleavage  
of C-N bond of aromatic methylamines
6
. However,  
to the best of our knowledge there is no method 
available for the preparation of 2,6-diaryl-4-
heteroarylpyridines. 
As part our ongoing research on 2-
chloronicotinaldehydes, we have reported 2-












. In continuation of our 
work on 2-chloronicotinaldehydes, the present 
manuscript has been designed to prepare 2-
chloronicotinaldehydes based 2',6'-diphenyl-3,4'-
bipyridines and biological evaluation of anti-
microbial, free radical scavenging and α-glucosidase 
inhibitory activities. 
 
Results and Discussion 
In an initial experiment, nicotinaldehyde (1a,  
1.0 equiv.), acetophenone (2a, 1.0 equiv.) and 
anhydrous NH4OAc (1.5 equiv.) were heated at 80°C 
for 6h with catalytic amount of Cu(OAc)2 (30 mol%, 
Scheme I). The compound was achieved in 54% yield 
after the column chromatography purification. The 
reaction was repeated at 120°C with 2.0 equiv of 
anhydrous ammonium acetate and the product 3a was 
obtained with improved yield (78%, Table I). Based 
on the spectral data, the compound was identified as 
2',6'-diphenyl-3,4'-bipyridine 3a. We have carried out 
the reaction of 1a with 2a with various catalysts such 
as p-TsOH, Cu(OTf)2, Bi(OTf)3, ZnCl2, Bi(NO3)2, 
Zn(OAc)2, Indium and I2. We have studied the 
reaction of 1a with 2a with various ammonium salts 
such as NH4F, NH4Cl, NH4Br, NH4NO3, (NH4)2CO3, 
and (NH4)2SO4. We identified NH4OAc (2 equiv.) 
—————— 
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with catalytic amount of Cu(OAc)2 at 120°C are the 
better condition to produce the compound 3a with 
very good yield. Having optimized conditions in 
hand, next, we have prepared series of target 
compounds 2',6'-diphenyl-3,4'-bipyridines 3b-t by the 
reaction of nicotinaldehydes 1a-b with acetophenones 
2a-j (Scheme I, Table I). All the prepared compounds 
are new and characterized by spectral data. 
 
Biology 
The compounds 2',6'-diphenyl-3,4'-bipyridines 3a-t 
have been evaluated for their biological activities
11
 
such as anti-microbial, free radical scavenging 
(DPPH, ABTS
.+
) and α-glucosidase inhibitory
 
and the 
results are described below. 
 
Anti-microbial activity 
All the compounds 3a-t were tested for anti-
microbial activity against two Gram-positive organisms 
(Bacillus subtilis, Staphylococcus epidermidis) and two 
Gram-negative organism (Pseudomonas aeruginosa, 
Escherichia coli) by agar well plate method and the 
results are presented in Table II. Five compounds 3n-r 
have shown moderate anti-bacterial activity against 
gram positive organism (B. subtilis) and compound 3n 
have shown significant anti-bacterial activity 
selectively against gram positive organism (S. 
epidermidis). Compounds 3m and 3n have shown 
significant anti-bacterial activity against gram negative 
organism E. coli. The structure activity relationships of 
the compounds revealed that the compounds 2-chloro 
2',6'-diphenyl-3,4'-bipyridines 3n-r were obtained with 
2-chloronicotinaldehydes have shown the anti-bacterial 
activity when compared to compounds obtained with 
nicotinaldehyde. Specifically the compound 3n have 
shown activity against S. epidermidis and similarly, the 
compounds 3m and 3n have shown activity selectively 
against E. coli. 
Anti-fungal activities of target the compounds 3a-t 
have been tested against Candida albicans and 
fluconazole was used as standard drug (Table II). The 
compound 3m have shown significant anti-fungal 
activity and 3n shown moderate activity in 
comparison with the standard drug. The structure 
activity relationships of the compounds revealed that 
the products 2-chloro 2',6'-diphenyl-3,4'-bipyridines 
3m-n were obtained with 2-chloronicotinaldehydes 
have shown the anti-fungal activity when compared to 
compounds obtained with nicotinaldehyde.  
In view of antimicrobial activity of 2',6'-diphenyl-
3,4'-bipyridines, compound 3m were further evaluated 
for MIC against those culture which revealed better 
anti-microbial activity. The compound 3m showed 
MIC value of 64 µg/mL
–1
 with E. coli and 32 µg/mL
–1
 
with C. albicans while standard compounds 
streptomycin depicted 8 µg/mL
–1
 and flucanzole 
depicted 2 mg/mL
–1
 suggesting that 3m compound is 
less effective in terms of MIC against the E.coli. 
However, compound 3m is more effective in terms of 
MIC than C. albicans. This observation is interesting 
to note that the anti-fungal activity by the above 
 
Table I — Preparation of nicotinaldehyde based 2',6'-diphenyl-
3,4'-bipyridines 3a-t 
Entry Compd X X R 
1 3a H H 
2 3b H 3-OCH3 
3 3c H 4-OCH3 
4 3d H 3,4-OCH3 
5 3e H 4-CH3 
6 3f H 4-F 
7 3g H 3-Cl 
8 3h H 4-Cl 
9 3i H 3-Br 
10 3j H 4-Br 
11 3k Cl H 
12 3l Cl 3-OCH3 
13 3m Cl 2,3-OCH3 
14 3n Cl 3,4-OCH3 
15 3o Cl 4-CH3 
16 3p Cl 3-Cl 
17 3q Cl 4-Cl 
18 3r Cl 2,4-Cl 
19 3s Cl 3-Br 
20 3t Cl 4-Br 








compound is greater than the standard which could be 
the alternative anti-fungal compound in the future. 
 
Free radicals scavenging activity 
The DPPH and ABTS.+ free radical scavenging 
activity of compounds 3a-t are presented in Table III 
along with the standard drugs Ascorbic acid and 
Trolox (SC50 values). These compounds could not 
show any free radical scavenging activity. 
 
α-Glucosidase inhibitory activity 
 α-Glucosidase inhibitory activity of compounds 
3a-t and their IC50 values presented in Table III along 
with the standard drug Acarbose. Five compounds 3d, 
3h, 3m, 3r & 3s have shown α-glucosidase inhibitory 
activity in the present series of compounds. The 
structure activity relationships of the compounds 
revealed that the compound 3d, 3m (dimethoxy 
substitution, IC50 7.65, 8.05 µg/mL) and 3r-s (chloro, 
bromo substitution, IC50 8.21, 15.26 µg/mL) has 
shown moderate α-glucosidase inhibitory activity. 
Compound 3h (chloro substitution, IC50 3.47 µg/mL) 




The chemicals were procured from Sigma-Aldrich 
and local suppliers. All the reactions were monitored 
by thin layer chromatography (TLC) on pre-coated 
silica gel 60 F254 (mesh); spots were visualized under 
UV light. Merck silica gel (100-200 mesh) was used 
for column chromatography. Melting points were 
determined in open glass capillary tubes on a Stuart 





C NMR spectra were recorded on an Avance 
300, 400 and 500 MHz spectrometer in CDCl3 using 
 
Table II — Anti-microbial activity profile of compounds 3a-t 
 Anti-bacterial Anti-fungal 
 Gram-positive Gram-negative  
Compd B. subtilis (MIC)* S. epidermidis P. aeruginosa (MIC)* E. coli C. albicans (MIC)* 
3a − − − − − 
3b − − − − − 
3c − − − − − 
3d − − − − − 
3e − − − − − 
3f − − − − − 
3g − − − − − 
3h − − − − − 
3i − − − − − 
3j − − − − − 
3k − − − − − 
3l − − − − − 
3m − − − 12 10 
3n 07 10 − 11 07 
3o 06 − − − − 
3p 06 − − − − 
3q 08 − − − − 
3r 06 − − − − 
3s − − − − − 
3t − − − − − 
Control 0 0 0 0 0 
Streptomycin 19 (8) 13 13 (8) 16 − 
Fluconazole − − − − 00* 
B. subtilis: Bacillus subtilis, S. epiderimidis: Staphylococcus epidermidis, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia 
coli, C. albicans: Candida albicans. 
*MIC (µg/mL): Minimum inhibitory concentration. 
The values represent the zone of inhibition in millimeter (mm) on agar plate against the represented microbial strains. The value in 
parentheses represents the MIC value (µg/mL). 
*Selected test strain (Fluconazole) has shown resistant against the standard drug.  
 





TMS as internal standard. IR spectra were recorded 
on a Nicolet 740 FT-IR spectrometer. Mass spectra 
were obtained on Agilent LCMS instrument. ESI-MS 
obtained on Quarto micro spectrometer. 
 
General procedure for the preparation of 2',6'-
diphenyl-3,4'-bipyridines, 3a-t 
Cu(OAc)2 (30 mol%) was added to a stirred 
reaction mixture of nicotinaldehyde (1a, 1.0 equiv.) 
acetophenone (2a, 2.0 equiv.) and anhydrous 
ammonium acetate (2.0 equiv.). The contents were 
heated at 120°C. The reaction was monitored by TLC 
and after completion of the reaction (6 h), the mixture 
was purified by column chromatography using silica 
gel (hexane:ethyl acetate) and afforded 2',6'-diphenyl-
3,4'-bipyridine 3a in 70% yield. Similarly, the 
compounds 3b-t were prepared by the reaction of 
nicotinaldehyde 1a and 2-chloronicotinaldehyde 2b 
with substituted acetophenones 2a-i under our 
optimized reaction conditions. All the prepared 
compounds are unknown and characterized by 
spectral data. 
 
2',6'-Diphenyl-3,4'-bipyridine, 3a: Yield 70%. 
Colorless solid. m.p. 164-166°C. FT-IR (KBr): 3447, 
3063, 2923, 1601, 1573, 1481, 1386, 1251, 1189, 




H NMR (500 MHz, CDCl3):  
δ 9.01 (s, 1H, aromatic), 8.73 (s, 1H, aromatic), 8.21 
(d, J = 7.3 Hz, 4H, aromatic), 8.04 (d, J = 7.8 Hz, 1H, 
aromatic), 7.88 (s, 2H, aromatic), 7.53 (t, J = 7.5 Hz, 
4H, aromatic), 7.47 (d, J = 7.2 Hz, 3H, aromatic); 
13
C NMR (125 MHz, CDCl3): δ 158.12, 150.14, 
148.34, 147.17, 139.33, 134.75, 134.55, 129.34, 






Yield 61%. Pale yellow solid. m.p. 128-130°C. FT-IR 




H NMR (400 MHz, CDCl3): δ 9.00 
(d, J = 1.7 Hz, 1H, aromatic), 8.73 (d, J = 3.5 Hz, 1H, 
aromatic), 8.20-8.00 (m, 1H, aromatic), 7.86 (s, 2H, 
aromatic), 7.82-7.78 (m, 2H, aromatic), 7.75 (dd,  
J = 7.7, 0.8 Hz, 2H, aromatic), 7.48-7.41 (m, 3H, 
aromatic), 7.04-7.00 (m, 2H, aromatic), 3.92 (s, 6H, 
2OCH3); 
13C NMR (101 MHz, CDCl3): δ 160.12, 
157.54, 150.09, 148.27, 146.98, 140.66, 134.61, 
129.81, 123.88, 119.55, 117.18, 114.96, 112.74,  





Yield 77%. Pale yellow solid. m.p. 134-136°C.  
FT-IR (KBr): 3424, 3037, 2837, 1605, 1513, 1428, 
1246, 1170, 1028, 834, 760 cm
−1; 1H NMR (300 
MHz, CDCl3): δ 9.00 (s, 1H, aromatic), 8.72 (s, 1H, 
aromatic), 8.16 (d, J = 8.8 Hz, 4H, aromatic), 8.02  
(d, J = 7.8 Hz, 1H, aromatic), 7.75 (s, 2H, aromatic), 
7.58-7.41 (m, 1H, aromatic), 7.04 (d, J = 8.8 Hz, 4H, 
aromatic), 3.89 (s, 6H, aromatic, 2OCH3); 
13
C NMR 
(75 MHz, CDCl3): δ 160.71, 157.29, 149.92, 148.27, 
146.76, 134.55, 131.95, 128.41, 123.84, 123.75, 






3d: Yield 73%. Pale yellow solid. m.p. 136-138°C. 
FT-IR (KBr): 3442, 3078, 2928, 2831, 1603, 1512, 
1459, 1397, 1262, 1175, 1023, 825, 793 cm
−1; 
 
Table III — DPPH, ABTS.+, α-glucosidase inhibitory (α-GI) 






(SC50 µg /ml) 
ABTS.+ 
% Inhibition 
20 µg /ml 




(IC50 µg /ml) 
3a ND ND ND 
3b ND ND 9.92 ± 0.00 
3c ND ND 13.40 ± 0.64 
3d ND ND 69.04 ± 0.32 (7.65) 
3e ND ND 17.49 ± 0.21 
3f ND ND 14.16 ± 0.00 
3g ND ND ND 
3h ND ND 83.12 ± 0.11 (3.47) 
3i ND ND ND 
3j ND 3.02 ± 0.47 48.30 ± 0.11 
3k ND ND 12.64 ± 1.28 
3l ND ND 2.95 ± 0.00 
3m ND ND 68.36 ± 0.43 (8.05) 
3n ND 27.63 ± 1.74 37.02 ± 0.21 
3o ND ND 4.77 ± 0.00 
3p ND ND 40.65 ± 0.00 
3q ND ND 45.27 ± 1.61 
3r ND ND 68.05 ± 0.00 (8.21) 
3s ND ND 61.01 ± 0.11 (15.26) 
3t ND ND 17.03 ± 0.00 
Ascorbic 
acid 
84.08 ± 0.12 − − 
Trolox − 98.88 ± 0.00 − 
Acarbose − − 89.17 ± 0.11 (2.79) 
 





H NMR (400 MHz, CDCl3): δ 9.01 (s, 1H, 
aromatic), 8.73 (s, 1H, aromatic), 8.04 (d, J = 7.9 Hz, 
1H, aromatic), 7.88 (d, J = 2.0 Hz, 2H, aromatic),  
7.83-7.70 (m, 4H, aromatic), 7.48 (dd, J = 7.7, 5.0 Hz, 
1H, aromatic), 7.01 (d, J = 8.4 Hz, 2H, aromatic), 
4.03 (s, 6H, aromatic, 2 OCH3), 3.97 (s, 6H, 2 OCH3); 
13C NMR (101 MHz, CDCl3): δ 157.20, 150.30, 
149.26, 148.21, 147.06, 146.84, 134.68, 132.18, 
123.89, 119.68, 115.74, 111.15, 110.21, 56.05,  




2',6'-Di-p-tolyl-3,4'-bipyridine 3e: Yield 70%. 
Colorless solid. m.p. 160-162°C. FT-IR (KBr): 3448, 




H NMR (400 MHz, CDCl3): δ 8.99 (d,  
J = 1.9 Hz, 1H, aromatic), 8.71 (dd, J = 4.8, 1.3 Hz, 
1H, aromatic), 8.10 (d, J = 8.2 Hz, 4H, aromatic), 
8.04-7.95 (m, 1H, aromatic), 7.81 (s, 2H, aromatic), 
7.45 (dd, J = 7.8, 4.9 Hz, 1H, aromatic), 7.32 (d,  
J = 8.0 Hz, 4H, aromatic), 2.48 (s, 6H, 2CH3); 
13
C NMR (101 MHz, CDCl3): δ 157.72, 149.99, 
148.32, 146.79, 139.30, 136.53, 134.92, 134.55, 






Yield 79%. Colorless solid. m.p. 232-234°C. FT-IR 
(KBr): 3442, 3044, 2924, 1719, 1607, 1510, 1215, 
1157, 829, 799 cm
−1 ; 1H NMR (500 MHz, CDCl3): δ 
8.99 (d, J = 2.2 Hz, 1H, aromatic), 8.74 (dd, J = 4.8, 
1.5 Hz, 1H, aromatic), 8.21-8.16 (m, 4H, aromatic), 
8.06-7.99 (m, 1H, aromatic), 7.81 (s, 2H, aromatic), 
7.48 (dd, J = 7.9, 4.8 Hz, 1H, aromatic), 7.24-7.18 (m, 
4H, aromatic); 
13
C NMR (125 MHz, CDCl3): δ 
164.79, 162.81, 156.86, 150.26, 148.28, 134.53, 
128.96, 128.93, 123.87, 116.50, 115.86, 115.69; ESI-





yl)pyridine 3g: Yield 75%. Colorless solid. m.p. 168-
170°C. FT-IR (KBr): 3874, 3593, 3309, 3013, 2360, 
1689, 1432, 1217, 813, 770, 674 cm
−1; 
1
H NMR (300 
MHz, CDCl3): δ 8.18 (s, 2H, aromatic), 8.05 (t,  
J = 6.0 Hz, 3H, aromatic), 7.87 (s, 3H, aromatic), 
7.50-7.43 (m, 6H, aromatic); 
13
C NMR (75 MHz, 
CDCl3): δ 156.58, 150.34, 148.22, 147.54, 140.72, 
134.99, 134.53, 130.56, 130.11, 129.47, 127.29, 





Yield 72%. Colorless solid. m.p. 228-230°C.  
FT-IR (KBr): 3442, 3073, 3035, 1901, 1601, 1546, 
1494, 1382, 1089, 831, 799 cm
−1; 
1
H NMR  
(400 MHz, CDCl3): δ 8.99 (s, 1H, aromatic), 8.75  
(s, 1H, aromatic), 8.13 (d, J = 8.6 Hz, 4H, aromatic), 
8.02 (d, J = 7.8 Hz, 1H, aromatic), 7.85 (d, J = 7.0 Hz, 
2H, aromatic), 7.50 (d, J = 8.6 Hz, 5H, aromatic); 
13
C NMR (101 MHz, CDCl3): δ 156.68, 150.28, 
148.22, 147.38, 137.37, 135.61, 134.51, 129.03, 




6'-Bis(3-bromophenyl)-3,4'-bipyridine, 3i: Yield 
71%. Pale brownish solid. m.p. 152-154°C. FT-IR 




H NMR (500 MHz, CDCl3): δ 8.33 
(s, 2H, aromatic), 8.21-8.02 (m, 4H, aromatic), 7.86 
(d, J = 10.7 Hz, 2H, aromatic), 7.70-7.53 (m, 4H, 
aromatic), 7.41 (t, J = 7.8 Hz, 2H, aromatic); 
13C NMR (125 MHz, CDCl3): δ 156.51,  
140.97, 134.70, 132.41, 130.40, 130.21, 128.89, 






Yield 64%. Pale brownish solid. m.p. 237-239°C. FT-
IR (KBr): 3422, 3034, 2923, 2851, 1906, 1604, 1577, 




(400 MHz, CDCl3): δ 8.99 (s, 1H, aromatic), 8.75 (s, 
1H, aromatic), 8.04 (dd, J = 18.5, 8.2 Hz, 5H, 
aromatic), 7.85 (s, 2H, aromatic), 7.66 (d, J = 8.5 Hz, 
4H, aromatic), 7.48 (dd, J = 7.6, 4.9 Hz, 1H, 
aromatic); 
13
C NMR (101 MHz, CDCl3): δ 156.81, 
156.68, 150.34, 148.26, 147.46, 137.84, 134.54, 





2-Chloro-2',6'-diphenyl-3,4'-bipyridine 3k: Yield 
82%. Colorless solid. m.p. 133-135°C. FT-IR (KBr): 
3448, 3060, 2104, 1599, 1557, 1416, 1381, 1241, 
1122, 776, 738 cm
−1; 1H NMR (400 MHz, CDCl3): δ 
8.50 (dd, J = 4.8, 1.9 Hz, 1H, aromatic), 8.20-8.17 (m, 
4H, aromatic), 7.84-7.76 (m, 3H, aromatic), 7.54-7.49 
(m, 4H, aromatic), 7.48-7.43 (m, 2H, aromatic), 7.40 
(dd, J = 7.5, 4.8 Hz, 1H, aromatic); 
13
C NMR (101 
MHz, CDCl3): δ 157.27, 149.55, 146.76, 139.38, 
139.08, 135.12, 129.36, 128.82, 127.16, 122.80, 
119.08; ESI-MS: m/z 343 [M+H]
+
. 






bipyridine 3l: Yield 81 %. Pale yellow solid. m.p. 
141-143°C. FT-IR (KBr): 3422, 3085, 3109, 3000, 
2904, 2832, 1912, 1748, 1667, 1595, 1044, 866, 687 
cm
−1; 1H NMR (400 MHz, CDCl3): δ 8.50 (dd, J = 
4.8, 1.9 Hz, 1H, aromatic), 8.07-7.57 (m, 7H, 
aromatic), 7.47-7.37 (m, 3H, aromatic), 7.01 (m, 2H, 
aromatic), 3.92 (s, 6H, 2OCH3); 
13
C NMR (101 
MHz, CDCl3): δ 160.12, 156.97, 149.56, 146.60, 
140.52, 139.38, 135.16, 129.81, 122.80, 119.55, 






bipyridine, 3m: Yield 72%. Pale yellow solid. m.p. 
130-132°C. FT-IR (KBr): 3420, 2926, 2842, 1649, 
1615, 1592, 1395, 1256, 1213, 1016, 825, 795 cm
−1; 
1
H NMR (400 MHz, CDCl3): δ 8.39 (dd, J = 4.7, 1.8 
Hz, 2H, aromatic), 7.99 (dd, J = 7.7, 1.7 Hz, 2H, 
aromatic), 7.91 (s, 1H, aromatic), 7.79 (s, 1H, 
aromatic), 7.51 (s, 1H, aromatic), 7.29 (dd, J = 7.6, 
4.7 Hz, 2H, aromatic), 6.60-6.58 (m, 1H, aromatic), 
6.50 (s, 1H, aromatic), 3.91 (s, 6H, 2 OCH3), 3.88 (s, 
6H, 2 OCH3); 
13
C NMR: (101 MHz, CDCl3): δ 
189.44, 164.69, 160.62, 151.62, 150.00, 136.09, 
135.98, 133.31, 131.55, 130.78, 122.78, 121.66, 





bipyridine, 3n: Yield 67%. Pale yellow solid. m.p. 
124-126°C. FT-IR (KBr): 3877, 3594, 2925, 2856, 
1659, 1593, 1518, 1412, 1271, 1214, 1162, 1024, 771, 
691 cm
−1; 1H NMR (400 MHz, CDCl3): δ 8.43 (d, J 
= 2.9 Hz, 1H, aromatic), 8.04 (dd, J = 6.5, 4.7 Hz, 2H, 
aromatic), 7.64 (d, J = 11.8 Hz, 3H, aromatic), 7.49 
(s, 1H, aromatic), 7.33 (dd, J = 7.6, 4.7 Hz, 2H, 
aromatic), 6.94 (d, J = 8.4 Hz, 2H, aromatic), 3.98 (s, 
12H, 4 OCH3); 
13
C NMR (101 MHz, CDCl3): δ 
188.04, 153.70, 151.71, 150.36, 149.43, 138.13, 
136.18, 126.57, 123.39, 122.82, 110.88, 110.04, 





Yield 79%. Colorless solid. m.p. 180-182°C. FT-IR 
(KBr): 3872, 3593, 3308, 3024, 2923, 2736, 2356, 
1915, 1773, 1606, 1551, 1391, 1217, 1120, 1069, 819, 
764 cm
−1; 1H NMR (500 MHz, CDCl3): δ 8.49 (dd, J 
= 4.8, 1.9 Hz, 1H, aromatic), 8.08 (d, J = 8.2 Hz, 4H, 
aromatic), 7.78 (dd, J = 7.5, 1.9 Hz, 1H, aromatic), 
7.71 (s, 2H, aromatic), 7.39 (dd, J = 7.5, 4.8 Hz, 1H, 
aromatic), 7.31 (d, J = 7.9 Hz, 4H, aromatic), 2.43 (s, 
6H, 2CH3).
13
C NMR (125 MHz, CDCl3): δ 157.17, 
149.45, 149.43, 146.56, 139.38, 139.32, 136.40, 
135.21, 129.51, 127.01, 122.75, 118.44, 21.38; ESI-
MS: m/z 371 [M+H]+. 
 
2-Chloro-2',6'-bis(3-chlorophenyl)-3,4'-
bipyridine 3p: Yield 73%. Colorless solid. m.p. 184-
186°C. FT-IR (KBr): 3873, 3592, 3378, 3068, 1599, 
1556, 1388, 1216, 1083, 879, 769, 699 cm
−1; 
1
H NMR (400 MHz, CDCl3): δ 8.52 (dd, J = 4.7, 1.8 
Hz, 1H, aromatic), 8.16 (s, 2H, aromatic), 8.12-8.01 
(m, 2H, aromatic), 7.89-7.72 (m, 3H, aromatic), 7.57-
7.37 (m, 5H, aromatic); 13C NMR (101 MHz, 
CDCl3): δ 156.05, 149.81, 140.59, 139.32, 134.99, 
130.12, 129.50, 127.29, 125.25, 122.84, 119.72; ESI-





bipyridine 3q: Yield 78%. Colorless solid. m.p. 214-
216°C. FT-IR (KBr): 3688, 3022, 2408, 2689, 1525, 
1427, 1367, 1215, 739, 671 cm
−1; 1H NMR (300 
MHz, CDCl3): δ 8.52 (d, J = 3.2 Hz, 1H, aromatic), 
8.11 (d, J = 8.6 Hz, 4H, aromatic), 7.82-7.70 (m, 3H, 
aromatic), 7.49 (d, J = 8.6 Hz, 4H, aromatic), 7.42 
(dd, J = 7.5, 4.8 Hz, 1H, aromatic); 
13
C NMR (75 
MHz, CDCl3): δ 156.68, 150.28, 148.22, 147.38, 
137.37, 135.61, 134.51, 129.03, 128.37, 116.86; ESI-





bipyridine 3r: Yield 77%. Colorless solid. m.p. 192-
194°C. FT-IR (KBr): 3875, 3593, 3546, 3385, 1798, 
1598, 1555, 1481, 1383, 1217, 1102, 1059, 820, 770, 
676 cm
−1; 1H NMR (500 MHz, CDCl3): δ 8.51 (dd, J 
= 4.8, 1.9 Hz, 1H, aromatic), 8.07-7.70 (m, 5H, 
aromatic), 7.59-7.35 (m, 5H, aromatic); 13C NMR 
(125 MHz, CDCl3): δ 155.94, 149.86, 145.36, 139.56, 
137.02, 135.36, 134.16, 133.03, 132.80, 130.07, 






3s: Yield 82%. Pale brownish solid. m.p. 184-186°C. 




H NMR (400 MHz, CDCl3): δ 8.53 




(dd, J = 4.8, 1.9 Hz, 1H, aromatic), 8.31 (t, J = 1.8 
Hz, 2H, aromatic), 8.11-8.06 (m, 2H, aromatic), 7.79-
7.75 (m, 3H, aromatic), 7.64-7.56 (m, 2H, aromatic), 
7.43 (dd, J = 6.1, 3.4 Hz, 2H, aromatic), 7.40 (s, 1H, 
aromatic); 13C NMR (101 MHz, CDCl3): δ 155.93, 
149.80, 147.22, 140.82, 139.32, 132.41, 130.39, 
130.18, 130.12, 125.74, 123.15, 122.85, 119.74; ESI-





3t: Yield 80%. Colorless solid. m.p. 218-220°C. FT-
IR (KBr): 3876, 3685, 3593, 3532, 3023, 2405, 1432, 
1215, 742, 671 cm
−1; 
1
H NMR (400 MHz, CDCl3): δ 
8.52 (dd, J = 4.7, 1.7 Hz, 1H, aromatic), 8.08 (dd, J = 
27.1, 8.6 Hz, 4H, aromatic), 7.82-7.71 (m, 3H, 
aromatic), 7.64 (d, J = 8.6 Hz, 3H, aromatic), 7.60-
7.27 (m, 2H, aromatic).
13
C NMR (101 MHz, CDCl3): 
δ 156.26, 149.75, 139.31, 137.72, 132.00, 129.04, 






Anti-bacterial activities of prepared compounds 
were evaluated against two Gram-positive organisms 
(Bacillus subtilis; Staphylococcus epidermidis) and 
two Gram-negative organisms (Pseudomonas 
aeruginosa; Escherichia coli) by agar well plate 
method by using streptomycin as standard
11
. The anti-
fungal activities of prepared compounds were 
evaluated against yeast (Candida albicans) and 
fluconazole was used as standard drug. 
 
Zone of inhibition plate tests 
Well plate method is followed for both the anti-
bacterial and anti-fungal activities for measuring the 
zone of inhibitions
11
. For anti-bacterial activity test 
strains used Gram positive and Gram negative in 
nutrient agar. For anti-fungal studies test strains used 
yeast and the medium used is potato dextrose agar. 
The synthesized compounds were used for activity 
studies and the concentration of each compound is 1.0 
mg/mL along with standard and control. The media, 
petri dishes were autoclaved at 121 ºC for 15 min. 
After sterilization the plates were poured with 
appropriate medium left over for 30 min for 
solidification, later the plates were inoculated with 60 
µl of test inoculum using sterile cotton swabs. An 8 
mm width size wells were made with sterile cork 
borer and in each well exactly 100 µl of sample were 
loaded. Control and standard also placed in separate 
wells. The plates were initially incubated for 20-30 
min at 4°C to allow the compounds to diffuse into the 
agar, and then subsequently incubated for 24 h at 
37°C for bacteria and 48 h at 28°C for fungi. Zone 
diameters were expressed in mm using calibrated 
scale. Experiment was triplicate to minimize the 
deviations. 
 
Determination of MIC and MBC 
Minimum inhibition concentration (MIC) is the 
lowest concentration of an anti-microbial agent that 
will inhibit the visible growth of a microorganism. 
The MIC was determined using the tube dilution 
method. The compounds were dissolved in dimethyl 
sulfoxide (DMSO) at concentration of 0.500 mg/mL 
(stock solution). The compounds having better anti-
microbial activity were selected for the MIC 
(minimum inhibitory concentration) and MBC 
(minimum bactericidal concentration) studies against 
all above microbial strains. The concentrations of test 
samples were serially diluted from 500 to 1.9 µg/mL 
and one tube without drug serves as control. All the 
tubes were inoculated with 1 mL of respective 
cultures having an OD of 0.2 (~ McFarland standard) 
and the tubes were incubated at 37°C for 16 h. The 
turbidity of each tube is measured with respect to 
control tube. MIC values are defined as the lowest 
concentration of compound at which growth is 
completely inhibited. After incubation the culture 
from each tube was spread on nutrient agar plates to 
evaluate the MBC concentration. The concentration at 
which the cells are completely dead was defined as 
MBC.Biological activity. 
 
DPPH scavenging activity 
Assay for the scavenging of stable free radical 
based on DPPH [1,1-diphenyl-2-picrylhydrazyl] was 
done as reported earlier was performed.
11
 Briefly, in a 
96-well micro plate, 25 µL of test sample dissolved in 
DMSO (1 mg/mL), 125 µL of 0.1 M tris-HCl buffer 
(pH 7.4) and 125 µL of 0.5 mM DPPH solution 
dissolved in absolute ethyl alcohol were added. The 
reaction mixture was shaken well and incubated in 
dark condition for 30 min and read at 517 nm 
spectrophotometrically (Spectra Max plus384, 
Molecular Devices Corporation, Sunnyvale, CA, 
USA). Percentage of DPPH scavenging was 
calculated as (1-B/ A) x 100 where ‘A’ represents 
absorbance of control without test samples and ‘B’ 
represents absorbance in presence of test samples. 







free radical scavenging assay 
Scavenging of the ABTS
+
 [2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid)] was 
performed as described by Walker and Everette with 
suitable modifications
11
. Briefly, 100 mL stock 
solution of ABTS
+
 (0.5 mM) was prepared by 
addition of 1 mL potassium persulfate (6.89 mM PBS, 
pH 8.0). The mixture was stored in the dark for 16 h. 
Test compounds were dissolved in DMSO (5mg/mL). 
Primary screening was done by mixing 10 µL of test 
compound in 100 µL of methanol followed by 190 µL 
of ABTS
+
 in a 96-well microplate. Absorbance of 
decolorized ABTS
+
 was measured at 734 nm after 15 
min incubation in the dark on a BioTek synergy4 multi-
mode microplate reader. For each test sample a 
separate blank sample (devoid of ABTS
+
) was used 
for background subtraction. The percentage of ABTS
+
 





 scavenging =    
[(Absorbancecontrol−Absorbancetest)/Absorbancecontrol   
                                                                             ×100] 
 
Various serial dilutions of active compounds were 
prepared and tested for determination of SC50 values. 
Suitable regression analysis was applied for 
calculation of SC50. 
 
Anti-hyperglycemic activity  
α-Glucosidase inhibitory activity was determined 
as per earlier reported method.
11 
Rat intestinal acetone 
powder in normal saline (100:1; w/v) was sonicated 
properly and the supernatant was used as a source of 
crude intestinal α-glucosidase after centrifugation. In 
brief, 20 µL of test samples (5 mg/mL DMSO 
solution) were reconstituted in 100 µL of 100 mM-
phosphate buffer (pH 6.8) in 96-well microplate and 
incubated with 50 µL of crude intestinal α-
glucosidase for 5 min before 50 µL substrate (5 mM, 
p-nitrophenyl- α-D-glucopyranoside prepared in same 
buffer) was added. Release of p-nitrophenol was 
measured at 405 nm spectrophotometrically (Spectra 
Max plus 384), Molecular Devices Corporation, 
Sunnyvale, CA, USA) 5 min after incubation with 
substrate. Individual blanks for test samples were 
prepared to correct background absorbance where 
substrate was replaced with 50 µL of buffer. Control 
sample contained 10 µL DMSO in place of test 
samples. Percentage of enzyme inhibition was 
calculated as (1-B/A) x 100 where ‘A’ represents 
absorbance of control without test samples and ‘B’ 
represents absorbance in presence of test samples. For 
calculation of 50% enzyme inhibitory activity 
(IC50%) more than five dilutions of primary 
screening concentration (5 mg/mL DMSO solution) 
of test compounds were prepared. The IC50 values 




In conclusion, series of 2',6'-diphenyl-3,4'-
bipyridines 3b-t have been prepared by the reaction of 
nicotinaldehydes 1a-b with acetophenones 2a-j in the 
presence of anhydrous NH4OAc with Cu(OAc)2 (30 
mol%) as the catalyst at 120°C. The target compounds 
were evaluated for anti-microbial, free-radical 
scavenging and α-glucosidase inhibitory activities. 
Compounds 3m and 3n have shown anti-microbial 
activity. Compound 3h have shown equi potent α-
glucosidase inhibitory activity when compared to 
standard compound. Compounds 3d, 3m, 3r and 3s 
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